Authors


Ryan Schuller, PharmD, BCOP

Latest:

Advancing LBCL Treatment Through MRD Monitoring and Allogeneic CAR T-Cell Therapy

A phase 2 trial investigates MRD detection and therapy advancements.


Sandra Casinghino, MS

Latest:

Sticking With It: A Meta-Review of Anti-Dementia Medication Use and Adherence

A recent meta-analysis reveals low persistence rates with anti-dementia drugs, highlighting factors influencing adherence and the need for standardized reporting.


Thomas Newcomer, MBA

Latest:

Looking Back to Go Forward: What 2023 Has Taught Us About Biosimilar Adoption

In 2024, there is an urgent need for policies that will accelerate biosimilar use to achieve lower system-wide health care costs.


Michelle Humeidan, MD, PhD

Latest:

Prioritizing Patient Pain Before Surgery Can Help Change the Trajectory of the Opioid Epidemic

Physician outlines the process developed at The Ohio State University Comprehensive Cancer Center to help manage patient pain before, during, and after surgery without the use of opioids.


Luis Alvarez

Latest:

The Biomedical Footprint of the Iraq War, Resulting Medical Innovation

In Iraq, asymmetrical warfare tactics relied heavily on unconventional weaponry, requiring military physicians to improvise new medical techniques in order to increase rates of survival.


Youn Chu, PharmD, RPh

Latest:

Pharmacists Play Key Role in Selecting Best RSV Vaccine for Older Adults

Differentiating between the 3 available options can help identify which is best for individual patients.



Tanya J. Uritsky, PharmD, BCPP

Latest:

Pseudodementia: The Deadly Impact of Stigmatizing Language in Psychiatric Care

Using the term "pseudodementia" contributes to the mismanagement and mistreatment of the disease.


Olivia Wierciszewski

Latest:

Pharmacists Can Help Treat Post-Intensive Care Syndrome

Managing transitions of care is vital to discontinue use of unnecessary drugs and minimize medication errors.


Sarah Morris, PharmD

Latest:

ASCO 2025: Cost Savings and Clinical Outcomes of Pre-Treatment DPYD Genotyping Before Fluoropyrimidine Therapy

Pre-treatment DPYD genotyping significantly reduces hospitalizations and costs for patients with cancer, enhancing safety and efficiency in oncology care.


Rachel L. Quinn, PharmD, BCACP, AE-C, CDCES

Latest:

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease

CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.


Scott Brunner, CAE

Latest:

Opinion: The FDA is in a Hole With MOU on Compounding Medications—It Should Stop Digging

Congress expected the FDA to draft a memorandum of understanding on interstate distributions of compounded medications that states would be willing to sign, but that’s not what the agency did.


Somtoochukwu Ojukwu, PharmD, MHS

Latest:

Going Back to the Basics: An Asthma Review

A review of asthma guidelines, pharmacotherapy, and the role of the pharmacist.


Daniel Rose, PharmD

Latest:

Heart Failure With Improved Ejection Fraction Is a Rising Focus in Cardiovascular Care

This subset of heart failure requires unique therapeutic considerations.


Megan Alhadeff, PharmD, MBA

Latest:

A Review of Anti-HER2 Targeted Agents in Non-Breast Solid Tumors

This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.


Caitlin A. Ritsch, PharmD candidate

Latest:

Veterans Mental Health Care Improvement Act of 2019 Expands Access

Four years after congress passed it, the Hannon Act is helping veterans get better care


Don V. Scigliano, PharmD Candidate

Latest:

FDA Approves Newest Antibody-Drug Conjugate for Cervical Cancer

Tisotumab vedotin-tftv is used as antitumor therapy for patients with disease progression during or after chemotherapy.


Khadijah Khan, PharmD

Latest:

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.


Kathryn Kane-Neilson, BS, CT (ASCP)

Latest:

Where's All This Waste Going? The Environmental Impact of Vaccinations in the Time of COVID-19

The COVID-19 pandemic has led to increased vigilance over the proper disposal of vaccine-related materials, such as vials, needles, syringes, and bandages.


Sasha Premraj, PharmD

Latest:

Scratch Beneath the Surface: ABSSSI

Consider key elements of acute bacterial skin and skin structure infection to help patients manage this broad range of diseases.


Amie Blaszczyk, PharmD, BCGP, BCPS, FASCP

Latest:

To Crush or Not to Crush: That is the Medication Administration Question

Pharmacists are well suited to identify patients with dysphagia and educate patients and caregivers on when and how to safely crush and administer medication.


Mekaliah Creese, PharmD, AAHIVP

Latest:

Optimizing Patient Visits: Implementing Immunizations Into the Ambulatory Clinic Workflow

Ambulatory care pharmacy residents play a major role in increasing both patient awareness about recommended vaccination and vaccination rates.


Cindy Jeter, CPhT, CPP, BGS

Latest:

Lessons Learned: Pharmacy Purchasing During a Pandemic

Pharmacies cannot prevent shortages, particularly with the complexities of treating COVID-19; however, they can strengthen their ability to prepare their organization to respond to those complexities.


Sherry Rais

Latest:

Psychedelic-Assisted Therapy: A Novel, Yet Effective Approach to Treating Mental Health Disorders

By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.


Kruti Rao, PharmD Candidate

Latest:

How Pharmacy Curricula Should Adjust to Abortion Legislature

Curricula should require comprehensive training for providing contraceptive care, helping students perform duties confidently and competently.


Karthik Ganesh, CEO of EmpiRx Health

Latest:

Pharmacy: The Missing Piece of the Value Puzzle

The necessary push for the health care industry to move to whole-person care instead of condition-oriented models and tactics for applying a value-based model in pharmacy benefits.


Lisa Cristofaro, PharmD, BS, BCACP

Latest:

What’s Ahead in the Adalimumab Biosimilar Pipeline in Dermatology

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.


Robert Mownn, PharmD

Latest:

Oncology Overview: Discovering the Therapeutic Value of Osimertinib Targeted Therapy

Osimertinib (Tagrisso; AstraZeneca) is FDA approved for 3 unique cancer indications.


Kimberly McCarthy, MS, BSN, RN

Latest:

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.


Erin R. Anderson

Latest:

Use Caution When Handling Controlled Substance Prescriptions

Technicians can help prevent drug diversion, provide care for patients with opioid use disorder.